BioSpace News Archive

Lannett Company, Inc. and Cediprof, Inc., a part of the Neolpharma Pharmaceutical Group family of companies, said that the companies have entered into an interim exclusive supply and distribution agreement for Cediprof’s FDA approved Levothyroxine Sodium Tablets USP.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced that the company will host a conference call and live webcast on Thursday, July 30, 2020 at 8:00 a.m.

Todos Medical Ltd. announced that its partner supplier 3D Medicines Corporation has received authorization from the Brazilian Health Surveillance Agency to distribute its COVID-19 qPCR test kits and ANDis extraction systems.

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the Company will release its second quarter 2020 financial results on Thursday, July 30, 2020 before the U.S. financial markets open.

AnchorDx, a leading biotechnology company developing novel NGS-based early cancer detection and disease monitoring tests, announced that it has entered into a multi-year collaboration with the Lung Cancer Initiative at Johnson & Johnson1, to conduct a lung cancer study.

Bristol-Myers Squibb Company announced the expiration and final results of its offers to exchange any and all of its outstanding $19,000,000,000 aggregate principal amount of senior unsecured notes previously issued on May 16, 2019 pursuant to an exemption from the registration requirements of the Securities Act of 1933

The United States Food and Drug Administration has approved one-way digital data streaming during patient support from Abiomed’s Automated Impella Controller, the external console used with Impella heart pumps.

MC2 Therapeutics, a commercial stage pharmaceutical company focused on topical therapies for chronic inflammatory conditions, announced the submission of its Marketing Authorization Application in EU for Wynzora® Cream ) for the treatment of plaque psoriasis.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation for rilonacept for the treatment of pericarditis, which includes recurrent pericarditis. Rilonacept is a weekly, subcuta

Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its second quarter 2020 financial results and corporate update conference call and live audio webcast on Thursday, July 23rd at 8:30 a.m. EDT. Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and referring to conference ID numbe